The company's facility in Pence's home state is working with Moderna on filling vials with the vaccine and preparing them for distribution. It has dozens of factories around the world and makes more than 70 billion doses of all kinds of drugs each year. Catalent is probably the biggest drugmaker you've never heard of. Vice President Mike Pence traveled to Bloomington, Ind., on Tuesday to tour Catalent, a contract manufacturing facility expected to help produce millions of Moderna coronavirus vaccines in the coming weeks and months. Still, the use of multiple companies to help make and package the vaccine stretches the supply and production chain and could add some risk to fulfillment of orders. Moderna is ultimately responsible for making sure the vaccine is made in compliance with regulations, and the FDA periodically inspects facilities around the world to make sure they are up to snuff. So how will Moderna make the 200 million doses it has contracted to provide the federal government for $3.2 billion by the end of June? A big part of the answer is outsourcing production to contract manufacturers that will make the vaccine on Moderna's behalf. READ MOREĪP News and Lead Stories also fact-checked these claims and found them to be unsupported.Shots - Health News Why I'm A Vaccine Volunteer: Doing What Needs To Be Done Therefore, Bancel’s declaration shouldn’t be seen as a prediction of the pandemic but rather as an anticipation of manufacturing needs, given the epidemiological data already available at the time. Thus, at the end of 2019 and the beginning of 2020, it was already clear that Moderna would have to scale up its manufacturing capacity. The SARS-CoV-2 genome was then published on 11 January 2020 and on 13 January 2020, the NIH and Moderna, who were already collaborating on other mRNA vaccines, finalized the mRNA sequence that would be used for the Moderna COVID-19 vaccine. organizations decided to start working on a vaccine in late December 2019 to early January 2020. Indeed, COVID-19 first started as an outbreak in late 2019 and was already monitored by international organizations. While the posts mentioned earlier used this quote as proof that Bancel knew about the COVID-19 pandemic, this is baseless. “ I remember walking into the office of my head of manufacturing and I said, ‘How will we make a billion doses next year?’ And he looked at me a bit funny, ‘Say what?’ I said, ‘Yeah, we need to make a billion doses next year, there’s going to be a pandemic”. In his response to the panel, Bancel continued: Furthermore, nowhere in the report is mentioned the development or production of mRNA vaccines for any coronavirus. Moderna’s report to investors for the third quarter of 2019 shows that Moderna’s pipeline had at least three mRNA vaccine candidates, for Zika, RSV, and CMV. Moderna has been producing mRNA therapeutics since 2010 and was already working on mRNA vaccine candidates for other diseases in 2019. In fact, Bancel was commenting on the general Moderna manufacturing capacity in 2019 for any kind of vaccines. Never did he specify that he was talking about COVID-19 vaccine doses. As Seth knows, when the pandemic happened, Moderna had made 100,000 doses in 2019 for the whole year”. “ The great news versus 2020, where we are today, is we’re at manufacturing capacity. However, this is a misinterpretation of Bancel’s declaration, as we explain below.Īsked about the manufacturing capacity of Moderna, Bancel said:
This declaration would have occurred during a panel titled “ The state of the pandemic” at the World Economic Forum in Davos on 18 January 2023. Health Feedback previously reviewed some of them and found them to be unsupported.Īnother iteration of that type of claim is that Stéphane Bancel, CEO of the COVID-19 mRNA vaccine company Moderna, declared that Moderna was already producing 100,000 doses of COVID-19 vaccines in 2019, prior to the pandemic. Related claims usually revolve around the alleged existence of COVID-19-related patents or products ahead of the pandemic onset. Since its beginning in early 2020, some people developed the narrative that the COVID-19 pandemic was planned.
Moderna covid 19 vaccine production capacity full#
FULL CLAIM: Moderna was already producing COVID-19 vaccines before the beginning of the pandemic its CEO, Stéphane Bancel, predicted the pandemic The COVID-19 outbreak in late 2019 and the decision to produce a vaccine against COVID-19 led the company to scale up its manufacturing capacity to address the possibility of an oncoming pandemic. In 2019, the company was able to produce around 100,000 doses of mRNA vaccines of any kind. National Institutes of Health before the COVID-19 pandemic. Moderna began to work on mRNA vaccines in 2010 and was already collaborating with the U.S.
0 kommentar(er)
